Insmed Inc (INSM)

[chem24_2000]

I really am not concerned about day to day price per share fluctuation. I am very excited about the fact that iPlex is now on the market. Huge milestone. Milestones for a biotech are getting through phase I to III studies, FDA approval, Marketing of product ( over coming production, logistics, sales force, etc), and finally revenue generation. The job of the company now is expand the market, by getting more and more indications. The revenue will start to flow in. As soon as INSM breaks the 5 per share magic barrier, institutional buyers can start really getting into the act. On the flip side, TRCA if they fall below 5 pps, some institutional holders will have to start selling. INSM is in a great position. This post is for the mature posters, not the idiot posters on Yahoo MB, but people who have experience in investing, especially biotech. This is a handicappers dream at current valuation. Good luck.